ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
45 announcements with these filters
Krsnaa Diagnostics Limited announced a board meeting scheduled for August 13, 2026, to discuss financial results for the quarter ending June 30, 2026, and fundraising proposals.
Krsnaa Diagnostics entered a PPP agreement with the Himachal Pradesh government to operate CT scan facilities at 34 health institutions, expanding from its previous 12 locations.
Krsnaa Diagnostics disclosed voting results for its postal ballot. Resolutions for re-appointing and appointing independent directors were passed with requisite majority.
ICRA has reaffirmed Krsnaa Diagnostics' credit ratings for bank facilities totaling ₹304.15 Crore. Long-term facilities are rated [ICRA]A(Stable) and short-term rated [ICRA]A1.
Krsnaa Diagnostics Limited issued a postal ballot notice for director re-appointments and commission approvals. Shareholders can vote electronically from June 5 to July 4, 2026.
Krsnaa Diagnostics reports 8% revenue growth and crossing ₹100cr PAT milestone in FY26, driven by PPP scaling and a sixfold growth in retail diagnostics.
Krsnaa Diagnostics reported FY26 revenue of ₹7,728 Mn (up 8% YoY) and PAT of ₹1,013 Mn (up 31% YoY). Strategy focuses on PPP model and aggressive retail expansion.
Krsnaa Diagnostics reported ₹772.8 Crore revenue for FY2026, with PAT growing 31% to ₹101.4 Crore. The company also declared a ₹2 final dividend per share.
Krsnaa Diagnostics filed its FY26 Annual Secretarial Compliance Report. The report confirms full adherence to SEBI regulations with no observed non-compliances or penalties.
Krsnaa Diagnostics recommended a final dividend of ₹2 per equity share for FY 2025-26. The record date and shareholder meeting for final approval are pending.
Krsnaa Diagnostics Ltd reported revenue from operations of ₹192.6 Cr (+3.5% YoY) and net profit of ₹41.7 Cr (+101.4% YoY) for Q4 FY26.
Krsnaa Diagnostics approved FY2026 financial results and recommended a final dividend of ₹2 per share. The company reported consolidated annual profit of ₹101.43 Crore.
Krsnaa Diagnostics received income tax demand notices totaling ₹11.31 Crore for two assessment years. The company is contesting these orders before appellate forums.
Krsnaa Diagnostics scheduled a board meeting for May 25, 2026. Directors will consider audited annual financial results and a potential final dividend declaration.
Krsnaa Diagnostics scheduled a board meeting for May 25, 2026. Directors will approve FY2026 audited financial results and recommend a potential dividend.